Inc. reported its fourth-quarter 2024 earnings with adjusted EPS of $2.95, slightly below the forecast of $2.97. Revenue also fell short, coming in at $2.29 billion against a forecasted $2.32 billion.
The global remote patient monitoring market, valued at US$24.39 billion in 2023, is forecasted to grow at a robust CAGR of 12.7%, reaching US$27.72 ...